These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38265254)

  • 21. Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology.
    Privé BM; Israël B; Schilham MGM; Muselaers CHJ; Zámecnik P; Mulders PFA; Witjes JA; Sedelaar M; Mehra N; Verzijlbergen F; Janssen MJR; Gotthardt M; Barentsz JO; van Oort IM; Nagarajah J
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):423-430. PubMed ID: 32999466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer.
    Tulsyan S; Das CJ; Tripathi M; Seth A; Kumar R; Bal C
    Nucl Med Commun; 2017 Dec; 38(12):1094-1102. PubMed ID: 28957842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer.
    Doan P; Counter W; Papa N; Sheehan-Dare G; Ho B; Lee J; Liu V; Thompson JE; Agrawal S; Roberts MJ; Buteau J; Hofman MS; Moon D; Lawrentschuk N; Murphy D; Stricker PD; Emmett L
    BJU Int; 2023 May; 131(5):588-595. PubMed ID: 36371669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer.
    Tran V; Hong A; Sutherland T; Taubman K; Lee SF; Lenaghan D; Sethi K; Corcoran NM; Lawrentschuk N; Woo H; Tarlinton L; Bolton D; Spelman T; Thomas L; Booth R; Hegarty J; Perry E; Wong LM
    BMJ Open; 2022 Sep; 12(9):e061815. PubMed ID: 36123093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.
    Yilmaz B; Turkay R; Colakoglu Y; Baytekin HF; Ergul N; Sahin S; Tugcu V; Inci E; Tasci AI; Cermik TF
    Prostate; 2019 Jun; 79(9):1007-1017. PubMed ID: 31012125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of [
    Mingels C; Bohn KP; Rominger A; Afshar-Oromieh A; Alberts I
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2436-2444. PubMed ID: 35067735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Ga-PSMA PET MRI with mpMRI in localization and regional staging of prostate cancer.
    Deka H; Pooleri GK; Suguna B; Rajeshkannan R; Sekhar R; Bindhu MR; Prasad V
    World J Urol; 2024 Mar; 42(1):153. PubMed ID: 38483621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the Detection Performance Between Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen PET/CT in Patients With Localized Prostate Cancer: A Systematic Review and Meta-analysis.
    Wang YF; Lo CY; Chen LY; Chang CW; Huang YT; Huang YY; Huang YH
    Clin Nucl Med; 2023 Jul; 48(7):e321-e331. PubMed ID: 37145456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Performance of
    Light A; Lazic S; Houghton K; Bayne M; Connor MJ; Tam H; Ahmed HU; Shah TT; Barwick TD
    J Nucl Med; 2024 Mar; 65(3):379-385. PubMed ID: 38212074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of
    Coşar U; Şen İ; Aydos U; Koparal MY; Uçar M; Tokgöz N; Gönül İI; Akdemir ÜÖ; Atay LÖ; Sözen TS
    Int J Clin Pract; 2021 Aug; 75(8):e14287. PubMed ID: 33931929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head-to-Head Comparison of
    Kuten J; Fahoum I; Savin Z; Shamni O; Gitstein G; Hershkovitz D; Mabjeesh NJ; Yossepowitch O; Mishani E; Even-Sapir E
    J Nucl Med; 2020 Apr; 61(4):527-532. PubMed ID: 31562225
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined Utility of
    Kalapara AA; Ballok ZE; Ramdave S; O'Sullivan R; Ryan A; Konety B; Grummet JP; Frydenberg M
    Eur Urol Oncol; 2022 Jun; 5(3):314-320. PubMed ID: 33741337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Status of
    Tang Y; Ji X; Lin Q; Huang H; Zhu H; Huang X; Xie H; Chen W; Zhuang Y
    World J Urol; 2023 Apr; 41(4):1017-1024. PubMed ID: 36932282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous
    Eiber M; Weirich G; Holzapfel K; Souvatzoglou M; Haller B; Rauscher I; Beer AJ; Wester HJ; Gschwend J; Schwaiger M; Maurer T
    Eur Urol; 2016 Nov; 70(5):829-836. PubMed ID: 26795686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraindividual comparison between
    Spohn S; Jaegle C; Fassbender TF; Sprave T; Gkika E; Nicolay NH; Bock M; Ruf J; Benndorf M; Gratzke C; Grosu AL; Zamboglou C
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2796-2803. PubMed ID: 32342192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison study of 68gallium-prostate-specific membrane antigen positron emission tomography-computed tomography and multiparametric magnetic resonance imaging for locoregional staging of prostate cancer.
    Patel KS; Singh T; Raghuvanshi K; Sonar S; Chaudhari R
    Urol Sci; 2024 Mar; 35(1):36-41. PubMed ID: 38566885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 68Ga-PSMA-I/T PET-CT and Multiparametric MRI for Locoregional Staging of Prostate Cancer Patients: A Pilot Study.
    Çelen S; Gültekin A; Özlülerden Y; Mete A; Sağtaş E; Ufuk F; Yüksel D; Yağcı B; Zümrütbaş AE
    Urol Int; 2020; 104(9-10):684-691. PubMed ID: 32750695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
    Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A
    Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer.
    Kaufmann S; Kruck S; Gatidis S; Hepp T; Thaiss WM; Hennenlotter J; Schwenck J; Scharpf M; Nikolaou K; Stenzl A; Reischl G; la Fougère C; Bedke J
    World J Urol; 2020 Oct; 38(10):2513-2521. PubMed ID: 31907632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison between
    Frumer M; Milk N; Rinott Mizrahi G; Bistritzky S; Sternberg I; Leibovitch I; Dekel Y; Amiel GE; Zisman A; Baniel J; Haifler M; Gal J; Hoffman A; Sagy I; Rosenzweig B; Haramaty R; Golan S
    Abdom Radiol (NY); 2020 Dec; 45(12):4194-4201. PubMed ID: 32671440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.